Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3653

GLP-1s may cut cancer risk; Gyre’s stock falls after hep B data and offering

$
0
0
Plus, news about Sanofi, Servier, BioNova, Arcutis, Roche, Satellos Bioscience, Fore Biotherapeutics, Cinclus Pharma and Zentiva: GLP-1 drugs could cut cancer risk: An academic, observational study published Friday ahead of ASCO’s annual meeting found that ...

Viewing all articles
Browse latest Browse all 3653

Trending Articles